A clinical trial of an investigational COVID-19 vaccine for individuals 12-17.
We are not currently enrolling for this study, but you can enter your name and email below to join the wait list.
*Note: Patients must live within a 1-hour drive of Nashville, Tennessee.
Given the widespread circulation of Omicron subvariants, the fight against COVID-19 is ongoing. There is a need to customize or update vaccines to combat these subvariants. Adolescents may only have mild to no symptoms but some can get severely ill with COVID. They can also spread the virus.
Insurance is not needed to participate, and participants will receive payment for their trial-related time and travel.
The purpose of this research study is to assess the safety and effectiveness of a monovalent vaccine or in combination with an emergency use authorized vaccine (bivalent) to protect against disease.
Parents, please consider allowing your child to participate in our COVID vaccine research study.
To be eligible your child must be:
- At least 12 years of age and not reached their 18th birthday.
- Previously received at least 2 COVID prevention injections.
- Willing to have an injection and blood draws.
- In good health.
All participants will have the opportunity to receive a non-mRNA COVID-19 vaccine.